China Resources Double-crane Pharmaceutical Co., Ltd. Class ASSE: 600062

"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining the Drug Registration Certificate for Ezetimibe and Atorvastatin Calcium Tablets by the Wholly-owned Subsidiary China Resources Saike Pharmaceutical Co., Ltd.

· Issued by China Resources Double-crane Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE ·

Announcement on Obtaining the Drug Registration Certificate for Ezetimibe and Atorvastatin Calcium Tablets by the Wholly-owned Subsidiary China Resources Saike Pharmaceutical Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from China Resources Double-crane Pharmaceutical Co., Ltd. Class A

All China Resources Double-crane Pharmaceutical Co., Ltd. Class A news releases